BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28159581)

  • 1. Recombinant expression of Intrepicalcin from the scorpion Vaejovis intrepidus and its effect on skeletal ryanodine receptors.
    Vargas-Jaimes L; Xiao L; Zhang J; Possani LD; Valdivia HH; Quintero-Hernández V
    Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):936-946. PubMed ID: 28159581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function relationships of peptides forming the calcin family of ryanodine receptor ligands.
    Xiao L; Gurrola GB; Zhang J; Valdivia CR; SanMartin M; Zamudio FZ; Zhang L; Possani LD; Valdivia HH
    J Gen Physiol; 2016 May; 147(5):375-94. PubMed ID: 27114612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of skeletal ryanodine receptors by two novel scorpion toxins from Buthotus judaicus.
    Zhu X; Zamudio FZ; Olbinski BA; Possani LD; Valdivia HH
    J Biol Chem; 2004 Jun; 279(25):26588-96. PubMed ID: 15067003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of inhibition of ryanodine receptor channels by imperatoxin I, a heterodimeric protein from the scorpion Pandinus imperator.
    Zamudio FZ; Conde R; Arévalo C; Becerril B; Martin BM; Valdivia HH; Possani LD
    J Biol Chem; 1997 May; 272(18):11886-94. PubMed ID: 9115249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide probe of ryanodine receptor function. Imperatoxin A, a peptide from the venom of the scorpion Pandinus imperator, selectively activates skeletal-type ryanodine receptor isoforms.
    el-Hayek R; Lokuta AJ; Arévalo C; Valdivia HH
    J Biol Chem; 1995 Dec; 270(48):28696-704. PubMed ID: 7499390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the structure-function of five newly members of the calcin family.
    Hua X; Yao J; Liu X; Liu Q; Deng Y; Li S; Valdivia CR; Wang F; Pozzolini M; Shou Z; Valdivia HH; Xiao L
    Int J Biol Macromol; 2024 Mar; 260(Pt 1):129424. PubMed ID: 38219929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical amino acid residues determine the binding affinity and the Ca2+ release efficacy of maurocalcine in skeletal muscle cells.
    Estève E; Smida-Rezgui S; Sarkozi S; Szegedi C; Regaya I; Chen L; Altafaj X; Rochat H; Allen P; Pessah IN; Marty I; Sabatier JM; Jona I; De Waard M; Ronjat M
    J Biol Chem; 2003 Sep; 278(39):37822-31. PubMed ID: 12869557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox-sensitive stimulation of type-1 ryanodine receptors by the scorpion toxin maurocalcine.
    Ronjat M; Finkelstein JP; Llanos P; Montecinos L; Bichraoui H; De Waard M; Hidalgo C; Bull R
    Cell Calcium; 2013; 53(5-6):357-65. PubMed ID: 23623374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of hadrucalcin, a peptide from Hadrurus gertschi scorpion venom with pharmacological activity on ryanodine receptors.
    Schwartz EF; Capes EM; Diego-García E; Zamudio FZ; Fuentes O; Possani LD; Valdivia HH
    Br J Pharmacol; 2009 Jun; 157(3):392-403. PubMed ID: 19389159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maurocalcine and peptide A stabilize distinct subconductance states of ryanodine receptor type 1, revealing a proportional gating mechanism.
    Chen L; Estève E; Sabatier JM; Ronjat M; De Waard M; Allen PD; Pessah IN
    J Biol Chem; 2003 May; 278(18):16095-106. PubMed ID: 12586831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple actions of phi-LITX-Lw1a on ryanodine receptors reveal a functional link between scorpion DDH and ICK toxins.
    Smith JJ; Vetter I; Lewis RJ; Peigneur S; Tytgat J; Lam A; Gallant EM; Beard NA; Alewood PF; Dulhunty AF
    Proc Natl Acad Sci U S A; 2013 May; 110(22):8906-11. PubMed ID: 23671114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tectoridins modulate skeletal and cardiac muscle sarcoplasmic reticulum calcium-release channels.
    Bidasee KR; Maxwell A; Reynolds WF; Patel V; Besch HR
    J Pharmacol Exp Ther; 2000 Jun; 293(3):1074-83. PubMed ID: 10869412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Channel Gating Dependence on Pore Lining Helix Glycine Residues in Skeletal Muscle Ryanodine Receptor.
    Mei Y; Xu L; Mowrey DD; Mendez Giraldez R; Wang Y; Pasek DA; Dokholyan NV; Meissner G
    J Biol Chem; 2015 Jul; 290(28):17535-45. PubMed ID: 25998124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imperatoxin A induces subconductance states in Ca2+ release channels (ryanodine receptors) of cardiac and skeletal muscle.
    Tripathy A; Resch W; Xu L; Valdivia HH; Meissner G
    J Gen Physiol; 1998 May; 111(5):679-90. PubMed ID: 9565405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scorpion toxins targeted against the sarcoplasmic reticulum Ca(2+)-release channel of skeletal and cardiac muscle.
    Valdivia HH; Kirby MS; Lederer WJ; Coronado R
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12185-9. PubMed ID: 1334561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ruthenium red modifies the cardiac and skeletal muscle Ca(2+) release channels (ryanodine receptors) by multiple mechanisms.
    Xu L; Tripathy A; Pasek DA; Meissner G
    J Biol Chem; 1999 Nov; 274(46):32680-91. PubMed ID: 10551824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and expression of recombinant toxins from Mexican scorpions of the genus Centruroides for production of antivenoms.
    Jiménez-Vargas JM; Quintero-Hernández V; González-Morales L; Ortiz E; Possani LD
    Toxicon; 2017 Mar; 128():5-14. PubMed ID: 28126552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional evolution of scorpion venom peptides with an inhibitor cystine knot fold.
    Gao B; Harvey PJ; Craik DJ; Ronjat M; De Waard M; Zhu S
    Biosci Rep; 2013 Jun; 33(3):. PubMed ID: 23721518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and functional effects of a deletion in a COOH-terminal lumenal loop of the skeletal muscle ryanodine receptor.
    Zorzato F; Yamaguchi N; Xu L; Meissner G; Müller CR; Pouliquin P; Muntoni F; Sewry C; Girard T; Treves S
    Hum Mol Genet; 2003 Feb; 12(4):379-88. PubMed ID: 12566385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide mimetic compounds can activate or inhibit cardiac and skeletal ryanodine receptors.
    Robinson K; Culley D; Waring S; Lamb GD; Easton C; Casarotto MG; Dulhunty AF
    Life Sci; 2020 Nov; 260():118234. PubMed ID: 32791148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.